AU Patent

AU2020203874B2 — Methods and compositions for treating depression using cyclobenzaprine

Assigned to Tonix Pharma Ltd Ireland · Expires 2021-09-09 · 5y expired

What this patent protects

The present invention relates to methods for the treatment or prevention of depression, and related pharmaceutical compositions. Of particular interest are pharmaceutical compositions comprising cyclobenzaprine, alone, or in combination with an antidepressant drug.

USPTO Abstract

The present invention relates to methods for the treatment or prevention of depression, and related pharmaceutical compositions. Of particular interest are pharmaceutical compositions comprising cyclobenzaprine, alone, or in combination with an antidepressant drug.

Drugs covered by this patent

Patent Metadata

Patent number
AU2020203874B2
Jurisdiction
AU
Classification
—
Expires
2021-09-09
Drug substance claim
No
Drug product claim
No
Assignee
Tonix Pharma Ltd Ireland
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.